Additional US Equity stories post the release of the US Equity Opening News

SourceNewsquawk
SectionUS Equities

NASDAQ 100

Bio-Marin (BMRN) – The co. announces it has entered into a definitive agreement to sell the Rate Paediatric Disease Priority Review Voucher it obtained in April for USD 125mln. (Newswires)

Other News

Barracuda (CUDA) – The co. has agreed to be acquired by Thoma Bravo for USD 27.55/shr valued at USD 1.6bln. (Newswires)

Teva Pharmaceuticals (TEVA) – The co. is no longer going to have two separate global groups for generics and specialty medicines. (Newswires)

Published: Updated:

Free. No signup, no card.

Use the Platform